摘要
肺动脉高压病因多样、病情复杂。肺动脉高压临床上主要分为5大类,其中第1大类为动脉性肺动脉高压(PAH)。对于PAH患者需综合多项指标对病情严重程度进行评估,包括临床特征、运动耐量、生物标志物、影像学及血流动力学指标等。《中国肺动脉诊断与治疗指南(2021版)》提出了以危险分层为导向的治疗策略。本文将结合该指南对PAH的功能评价、PAH综合评估及危险分层等进行解读。
Pulmonary hypertension is a complex condition with various etiologies.Pulmonary hypertension has been divided into five distinct categories in clinical practice.Category 1 is pulmonary arterial hypertension(PAH).For PAH patients,a comprehensive assessment including clinical characteristics,exercise capacity,biomarkers,imaging and hemodynamic parameters is required for the evaluation of severity of PAH.A risk-oriented management strategy was offered in"Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension in China(2021 Edition).In this paper,a detailed interpretation of functional evaluation,PAH comprehensive evaluation and risk stratification of PAH is carried out.
作者
张萌
万钧
Zhang Meng;Wan Jun(Department of Respiratory and Critical Care Medicine,Beijing Anzhen Hospital,Capital Medical University,Beijing 100029,China)
出处
《国际呼吸杂志》
2022年第5期332-337,共6页
International Journal of Respiration
基金
中国医学科学院医学与健康科技创新工程项目2020年临床与转化医学研究基金(2020-I2M-C&T-B-095)。
关键词
肺动脉高压
功能评价
危险分层
Pulmonary hypertension
Functional evaluation
Risk stratification
